Silvaco Group Inc
For the period ended Dec 31, 2024. Filed Mar 5, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 5, 2025
SVCO$7.45+2.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(in thousands)
| Year Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net loss | $(39,404) | $(316) |
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||
| Depreciation and amortization | 1,285 | 601 |
| Stock-based compensation expense | 26,915 | — |
| Provision for credit losses | 351 | 220 |
| Accretion of discount on marketable securities, net | (1,685) | — |
| Estimated litigation claim | 11,306 | — |
| Loss on debt extinguishment | 718 | — |
| Change in fair value of contingent consideration | (27) | 325 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (5,971) | 1,378 |
| Contract assets | (10,293) | (5,208) |
| Prepaid expense and other current assets | (790) | 133 |
| Other assets | 57 | (267) |
| Accounts payable | 1,326 | 156 |
| Accrued expenses and other current liabilities | (2,160) | 2,015 |
| Accrued income taxes | 74 | (23) |
| Deferred revenue | (1,585) | 2,268 |
| Other non-current liabilities | 109 | (102) |
| Net cash (used in) provided by operating activities | (19,774) | 1,180 |
| Cash flows from investing activities: | ||
| Purchases of marketable securities | (99,630) | — |
| Maturities of marketable securities | 33,600 | — |
| Purchases of property and equipment | (505) | (339) |
| Net cash used in investing activities | (66,535) | (339) |
| Cash flows from financing activities: | ||
| Proceeds from initial public offering, net of underwriting fees | 106,020 | — |
| Proceeds from issuance of convertible note, net of debt issuance costs | 4,852 | — |
| Proceeds from loan facility | 4,250 | — |
| Repayment of loan facility | (4,250) | — |
| Proceeds from related party line of credit | — | 1,000 |
| Repayment of related party line of credit | (2,000) | (1,000) |
| Proceeds from issuance of common stock for share-based awards | 315 | — |
| Payroll taxes related to shares withheld from employees | (4,575) | — |
| Deferred transaction costs | (2,649) | (650) |
| Contingent consideration | (74) | (1,002) |
| Payments of vendor financing obligation | (588) | — |
| Net cash provided by (used in) financing activities | 101,301 | (1,652) |
| Effect of exchange rate fluctuations on cash and cash equivalents | 193 | (246) |
| Net increase (decrease) in cash and cash equivalents | 15,185 | (1,057) |
| Cash and cash equivalents, beginning of period | 4,421 | 5,478 |
| Cash and cash equivalents, end of period | $19,606 | $4,421 |
| Supplemental disclosures of cash flow information: | ||
| Income taxes paid | $625 | $655 |
| Interest paid | $498 | $71 |
| Noncash investing and financing activities: | ||
| Deferred offering costs incurred, not yet paid | $— | $513 |
| Right of use assets obtained in exchange for lease obligations | $607 | $452 |
| Issuance of equity upon Micron Note conversion | $5,589 | $— |
| Financial obligation incurred upon acquisition of NXP IP | $4,979 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.